Nygaard TG, Wilhelmsen KC, Risch NJ, et al: Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 5:386, 1993.
Oba H, Yagashita A, Terada H, et al: New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050, 2005.
Okazaki H, Lipkin LE, Aronson SM: Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 20:237, 1961.
Okun MS: Deep-brain stimulation for Parkinson’s disease. N Engl J Med 367:1529, 2012.
Olanow CW, Rascol O, Hauser R, et al: A double-blind delayed start trial of rasagiline in Parkinson’s disease. N Engl J Med 361:1268, 2009.
Oppenheim H: Textbook of Nervous Diseases (A. Bruce, transl). Edinburgh, Schulze, 1911, p 512.
Orgogozo JM, Gilman S, Dartigues JF, et al: Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61:46, 2003.
Pakkenberg B, Moller A, Gundersen HJG, et al: The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson’s disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 54:30, 1991.
Papapetropoulos S, Singer C, Ross OA, et al: Clinical heterogeneity of the LRRK2 G2019S mutation. Arch Neurol  63:1242, 2006.
Papp MI, Kahn JE, Lantos PL: Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79, 1989.
Parkkinen L, O’Sullivan SS, Kuoppamaki M, et al. Does levodopa accelerate the pathologic process in Parkinson disease brain? Neurology 77:1420, 2011.
PD Med Collaborative Group: Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet 384:1196, 2014.
Pearn J: Classification of spinal muscular atrophies. Lancet 1:919, 1980.
Perry RJ, Hodges JR: Attention and executive deficits in Alzheimer’s disease. Brain 122:383, 1999.
Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303, 1999.
Piccini P, Burn DJ, Ceravolo R, et al: The role of inheritance in sporadic Parkinson’s disease: Evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45:577, 1999.
Pick A: Uber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prager Med Wochenschr 17:165, 1892.